Results

Total Results: 2,078 records

Showing results for "drugs".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
    April 01, 2013 - List of Drugs Approved Using Studies With a Primary Endpoint of PFS Appendix D. … These drugs are not expected to provide the same objective response rates of earlier drugs, and instead … To answer KQ2 we identified a targeted sample of drugs. … For KQ2, a targeted search strategy included the identified drugs of interest—drugs approved for treatment … List of Drugs Approved Using Studies With a Primary Endpoint of PFS Oncology drugs for advanced
  2. effectivehealthcare.ahrq.gov/health-topics/femur-neck
    April 12, 2018 - Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention Research Protocol April 12, 2018 Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review Systematic Review April 23, 2019
  3. effectivehealthcare.ahrq.gov/products/erythropoiesis-stimulating-agents-utilization/research
    March 31, 2011 - Erythropoiesis-stimulating agents (ESAs) are recombinant hematopoietic drugs that stimulate the production
  4. effectivehealthcare.ahrq.gov/health-topics/quality-life
    August 08, 2018 - Synthesizing Evidence for Quality Improvement Abstract August 8, 2018 Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention Research Protocol April 12, 2018 Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic…
  5. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Results The table below lists the seven topics for which (1) preliminary phase III data on drugs or … to several weeks, following a single infusion. 29,33,34 The drug was launched in 1966 by King PharmaceuticalsDrugs Future 2009;34(3):217-21. 31. Thomson Reuters Integrity [database online]. … In: Drugs@FDA [internet]. Silver Spring (MD): U.S.
  6. effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/research-protocol
    July 01, 2014 - CNS Drugs. 2006;20(7):549-65. PMID: 16800715 Newcorn JH, Ivanov I. … (Ativan®) BTA Pharmaceuticals Inc., Bridgewater, NJ Bupropion Mylan Pharmaceuticals Inc., Morgantown … New York, NY Citalopram Teva Pharmaceuticals, Sellersville, PA Escitalopram Teva Pharmaceuticals … , Sellersville, PA Paroxetine Teva Pharmaceuticals, Sellersville, PA Fluvoxamine Mylan Pharmaceuticals … ") OR SU.EXACT.EXPLODE("Adrenergic Drugs")) OR (SU.EXACT.EXPLODE("Anticonvulsive Drugs") OR SU.EXACT.EXPLODE
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
    November 27, 2012 - Peer Reviewer #1 Introduction The gabapentin- pregabalin group of drugs is called “GABA analogs”. … This complication can occur in 9- 17% of RLS patients using these drugs. … First, FDA approved drugs include rotigotine (probably approved after submission) and gabapentin enacarbil … was not identified as a therapy commonly used and we identified no eligible studies examining these drugs … Since most of the report does not actually compare drugs, why can these not be included?
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
    April 21, 2015 - Prescribing behavior has changed with the approval of new drugs and the availability of new evidence … for efficacy, comparative effectiveness, and harms.6 Table 1 provides a list of drugs commonly used … and enlarged prostates with either agent are supported by systematic reviews.10, 13 Recently, newer drugs … A new AB, silodosin, was approved for the treatment of BPH in 2008.7 Several anticholinergics drugs … symptoms such as urgency, frequency, and nocturia, which may or may not be causally related.15 These drugs
  9. effectivehealthcare.ahrq.gov/products/nsaids-safety-data-mining/research
    December 02, 2009 - who were exposed to cyclooxygenase selective (coxib) or nonselective nonsteroidal anti-inflammatory drugs
  10. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the two topics for which (1) preliminary phase III data on drugs, phase … A third topic that was in the December 2013 report, the oral tablet ivacaftor (Kalydeco™, Vertex Pharmaceuticals
  11. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/fibromyalgia-very-few-doctors-know-how-to-treat-this-pain-some-states-there-are-really-none-more-more-are-being-diagnosed-but-no-treatment-especially-with-severe-pain-fibro-brings-on-ibs-migrainesno-sleep-ect-a-lot-of-meds-ha
    November 01, 2011 - no If yes, explain the specific technologies, devices, drugs, or interventions you would like to
  12. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/iron-deficiency-anemia-in-renal-dialysis-patients
    June 17, 2008 - None If yes, explain the specific technologies, devices, drugs, or interventions you would like to
  13. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/can-anything-be-done-to-improve-diabetic-periphheral-neuropathywhat-is-truly-effective-what-research-seems-promising-diabetes-type-2well-controlled
    April 02, 2013 - no If yes, explain the specific technologies, devices, drugs, or interventions you would like to
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_consumer.pdf
    February 01, 2016 - Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: � Your doctor* said you have alcohol use disorder and need to stop drinking or cut down the amount you drink. � You have decided to stop or cut down your dri…
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - Pharmacotherapy for Adults With Alcohol Use Disorder (AUD) in Outpatient Settings Focus of This Summary This is a summary of a systematic review evaluating the evidence regarding the efficacy, comparative effectiveness, and adverse effects of medications in adults with alcohol use disorder (AUD). The systematic revi…
  16. effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
    January 01, 2007 - Assessment of Adherence to and Persistence on Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Patients … Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic
  17. effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
    May 26, 2016 - Included trials did not report the impact of the combination of these drugs on blood pressure and we … We revised the sentence to clarify: “Recently, newer drugs and drug in other classes approved for … All drugs are FDA-approved and therefore likely to have trials published in English. … We included drugs ‘newly used’ to treat LUTS attributable to BPH. … Drugs with insufficient evidence were added to the anticholinergics paragraph.
  18. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
    January 01, 2020 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Along with access to relatively inexpensive illicit opioid drugs, such as heroin, and increased use … Available: http://www.accessdata.fda.gov/scripts/cder/drugs atfda/index.cfm? … For drugs that save lives, a steep cost. [internet].
  19. effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
    January 01, 2013 - Example: When comparing the adverse metabolic effects of antipsychotic drugs, body mass index is a potential … study assessing the risk of cancer in statin users, an active comparator group of patients on glaucoma drugs … Although device or drug registries may provide detailed data on the use of drugs, biologics, and devices … Different Treatment Modalities (1 of 3) Confounding by Indication or Severity For some conditions, drugs … Adherence to Drugs and Device Failure or Removal Patients who are on medications could have various degrees
  20. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
    October 01, 2006 - comparing angioplasty with stent placement and “aggressive” medical treatment with currently available drugs … after revascularization do occur in a small percentage of patients, and each of the antihypertensive drugs … blood pressure generally decreased by 20-50/8-42 mm Hg with combinations of multiple antihypertensive drugs … eligibility criteria reported analyses of whether other periprocedural interventions, such as different drugs … eligibility criteria reported analyses of whether other periprocedural interventions, such as different drugs

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: